Astrocytes regulate myelin clearance through recruitment of microglia during cuprizone-induced demyelination
Abstract
Recent evidence suggests that astrocytes play an important role in regulating de- and remyelination in multiple sclerosis. The role of astrocytes is controversial, and both beneficial as well as detrimental effects are being discussed. We performed loss-of-function studies based on astrocyte depletion in a cuprizone-induced rodent model of demyelination. This led to strong astrogliosis accompanied by microgliosis and demyelination in C57BL/6 wild-type mice. Ablation of astrocytes in glial fibrillary acidic protein-thymidine kinase transgenic mice was associated with a failure of damaged myelin removal and a consecutive delay in remyelination. Despite oligodendrocyte death, myelin was still present, but ultrastructual investigations showed that the myelin structure was loosened and this damaged myelin did not protect axons. These alterations were associated with a decrease in microglial activation. Thus, our results show that astrocyte loss does not prevent myelin damage, but clearance of damaged myelin through recruitment of microglia is impaired. Further studies suggest that this process is regulated by the chemokine CXCL10. As a consequence of the delayed removal of myelin debris, remyelination and oligodendrocyte precursor cell proliferation were impaired. Experiments omitting the influence of myelin debris demonstrated an additional beneficial effect of astrocytes on oligodendrocyte regeneration during remyelination. In conclusion, these data demonstrate for the first tim…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Activation of innate immunity within demyelinated regions during cuprizone treatment lasts about 1 month, which is shorter than the 2-4 months necessary for progression onset in NOD animals.
“It is worth noting, indeed, that activation of innate immunity within demyelinated regions during cuprizone treatment (Fig. 2 and (Skripuletz et al. 2013)) lasts for an extent of time of about 1 month that is shorter than that of 2–4 months necessary for progression onset in NOD animals (Buonvicino et al. 2019).”
From Cuprizone-Dependent De/Remyelination Responses and Functional Correlates in Mouse Strains Adopted to Model Relapsing, Chronic and Progressive Experimental Autoimmune Encephalomyelitis (2021) · cites this paper as Skripuletz et al. 2013
CXCL10 is an important attractant for microglia during cuprizone treatment.
“– an important attractant for microglia during cuprizone treatment [184–186].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [185]
Astrocytes secrete CXCL10 in vitro following stimulation with IFN-γ or TNF-α.
“Astrocytes were also shown to secrete CXCL10 in vitro following stimulation with IFN-γ or TNF-α [185].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [185]
Astrocytes are responsible for the recruitment of microglia.
“It was concluded, that astrocytes are responsible for the recruitment of microglia.”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Skripuletz et al., 2013
Ablation of astrocytes during cuprizone-induced demyelination resulted in diminished activation and invasion of microglia into the demyelinated lesion.
“but resulted in a diminished activation and invasion of microglia into the demyelinated lesion.”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Skripuletz et al., 2013
As a consequence of astrocyte ablation, removal of myelin debris was delayed and subsequent OPC proliferation and remyelination were delayed.
“As a consequence the removal of myelin debris was delayed and subsequent OPC proliferation and remyelination were delayed.”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Skripuletz et al., 2013
Ablation of astrocytes during cuprizone-induced demyelination had no impact on the loss of mature oligodendrocytes and on axonal damage.
“Ablation of astrocytes during cuprizone-induced demyelination had no impact on the loss of mature oligodendrocytes and on axonal damage, but resulted in a diminished activation and invasion of microglia into the demyelinated lesion.”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Skripuletz et al., 2013
Depletion of astrocytes resulted in diminished numbers of mature oligodendrocytes during remyelination.
“In addition, the depletion of astrocytes resulted in diminished numbers of mature oligodendrocytes during remyelination (Skripuletz et al., 2013).”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Skripuletz et al., 2013
Astrocyte-derived factors mediate attraction of microglia.
“arguing for astrocyte-derived factors that mediate attraction of microglia.”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Skripuletz et al., 2013
In astrocyte-ablated mice, clearance of damaged myelin and recruitment of microglia were strongly impaired.
“However, the clearance of damaged myelin as well as the recruitment of microglia was strongly impaired in this experimental setting”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Skripuletz et al., 2013
Partial ablation of astrocytes in mice challenged for 3 weeks with cuprizone did not reveal any difference in CCL2 and CCL3 expression.
“Interestingly, a partial ablation of astrocytes in mice challenged for 3 weeks with cuprizone did not reveal any difference in CCL2 and CCL3 expression”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Skripuletz et al., 2013
We detected up-regulated expression of CCL2 and CCL3 upon cuprizone treatment.
“In line with other studies (McMahon et al., 2001; Buschmann et al., 2012) we could also detect an up-regulated expression of CCL2 and CCL3 upon cuprizone treatment (Skripuletz et al., 2013).”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Skripuletz et al., 2013
Treatment of astrocyte cultures with LPS, IL-1β, or TNF-α led to an enhancement of CXCL10 production in vitro.
“and the treatment of astrocyte cultures with LPS, IL-1β, or TNF-α led to an enhancement of CXCL10 production in vitro (Skripuletz et al., 2013).”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Skripuletz et al., 2013
CXCL10 mRNA expression was reduced in astrocyte-depleted mice.
“Our studies suggested that this process may be regulated by the chemokine CXCL10 since CXCL10 mRNA expression was reduced in the astrocyte-depleted mice”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Skripuletz et al., 2013
This process may be regulated by the chemokine CXCL10.
“Our studies suggested that this process may be regulated by the chemokine CXCL10”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Skripuletz et al., 2013
CCL2 and CCL3 are not astrocyte-derived at least at this time point.
“suggesting that these cytokines are not astrocyte-derived at least at this time point (Skripuletz et al., 2013).”
From Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned (2014) · cites this paper as Skripuletz et al., 2013
Cites
Matsushima, G. K., & Morell, P. (2001) · Brain Pathology · doi:10.1111/j.1750-3639.2001.tb00385.x · Cited by 984 · see citing works
Myelin Impairs CNS Remyelination by Inhibiting Oligodendrocyte Precursor Cell Differentiation
Kotter, M. R., Li, W.-W., Zhao, C., & Franklin, R. J. M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2615-05.2006 · Cited by 768 · see citing works
Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis
Boven, L. A., Van Meurs, M., Van Zwam, M., Wierenga-Wolf, A., Hintzen, R. Q., Boot, R. G., Aerts, J. M., Amor, S., Nieuwenhuis, E. E., & Laman, J. D. (2006) · Brain · doi:10.1093/brain/awh707 · Cited by 353 · see citing works
Inflammation, demyelination, and degeneration — Recent insights from MS pathology
Stadelmann, C., Wegner, C., & Brück, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.007 · Cited by 276 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Regenerating CNS myelin — from mechanisms to experimental medicines
Franklin, R. J. M., & ffrench-Constant, C. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.136 · Cited by 647 · see citing works
Inefficient clearance of myelin debris by microglia impairs remyelinating processes
Lampron, A., Larochelle, A., Laflamme, N., Préfontaine, P., Plante, M.-M., Sánchez, M. G., Yong, V. W., Stys, P. K., Tremblay, M.-È., & Rivest, S. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141656 · Cited by 595 · see citing works
An Efficient Platform for Astrocyte Differentiation from Human Induced Pluripotent Stem Cells
TCW, J., Wang, M., Pimenova, A. A., Bowles, K. R., Hartley, B. J., Lacin, E., Machlovi, S. I., Abdelaal, R., Karch, C. M., Phatnani, H., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.06.018 · Cited by 435 · see citing works
Praet, J., Guglielmetti, C., Berneman, Z., Van der Linden, A., & Ponsaerts, P. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.10.004 · Cited by 435 · see citing works
van der Knaap, M. S., & Bugiani, M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1739-1 · Cited by 403 · see citing works
The pro-remyelination properties of microglia in the central nervous system
Lloyd, A. F., & Miron, V. E. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0184-2 · Cited by 381 · see citing works
Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned
Gudi, V., Gingele, S., Skripuletz, T., & Stangel, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00073 · Cited by 375 · see citing works
“Demyelination peaks between 4.5 and 5 weeks of cuprizone exposure in the CC and between 5 and 6 weeks in the cortex and hippocampus (Hiremath et al., 1998; Matsushima and Morell, 2001; Skripuletz et al., 2008; Gudi et al., 2009; Koutsoudaki et al., 2009).”
BackgroundInfluentialSelf-citationTREM2 regulates microglial cell activation in response to demyelination in vivo
Cantoni, C., Bollman, B., Licastro, D., Xie, M., Mikesell, R., Schmidt, R., Yuede, C. M., Galimberti, D., Olivecrona, G., Klein, R. S., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1388-1 · Cited by 296 · see citing works
Zirngibl, M., Assinck, P., Sizov, A., Caprariello, A. V., & Plemel, J. R. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00538-8 · Cited by 233 · see citing works
The benefits and detriments of macrophages/microglia in models of multiple sclerosis
Rawji, K. S., & Yong, V. W. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/948976 · Cited by 217 · see citing works
“[80] ablated astrocytes in the”
Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration
Molina-Gonzalez, I., Holloway, R. K., Jiwaji, Z., Dando, O., Kent, S. A., Emelianova, K., Lloyd, A. F., Forbes, L. H., Mahmood, A., Skripuletz, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39046-8 · Cited by 176 · see citing works
“We induced astrocyte death during remyelination using transgenic mice in which GFAP-driven expression of thymidine-kinase renders astrocytes selectively vulnerable to apoptosis following ganciclovir administration, using the cuprizone model where this paradigm has been previously optimised 12 .”
Self-citationCXCL10 Triggers Early Microglial Activation in the Cuprizone Model
Clarner, T., Janssen, K., Nellessen, L., Stangel, M., Skripuletz, T., Krauspe, B., Hess, F.-M., Denecke, B., Beutner, C., Linnartz-Gerlach, B., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401459 · Cited by 150 · see citing works
Self-citationZhang, C., Cheng, N., Qiao, B., Zhang, F., Wu, J., Liu, C., Li, Y., & Du, J. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12584 · Cited by 105 · see citing works
Hou, J., Zhou, Y., Cai, Z., Terekhova, M., Swain, A., Andhey, P. S., Guimaraes, R. M., Ulezko Antonova, A., Qiu, T., Sviben, S., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112293 · Cited by 85 · see citing works
Guglielmetti, C., Le Blon, D., Santermans, E., Salas-Perdomo, A., Daans, J., De Vocht, N., Shah, D., Hoornaert, C., Praet, J., Peerlings, J., et al. (2016) · Glia · doi:10.1002/glia.23053 · Cited by 76 · see citing works
Butti, E., Bacigaluppi, M., Chaabane, L., Ruffini, F., Brambilla, E., Berera, G., Montonati, C., Quattrini, A., & Martino, G. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0227-18.2019 · Cited by 67 · see citing works
Lavrnja, I., Smiljanic, K., Savic, D., Mladenovic-Djordjevic, A., Tesovic, K., Kanazir, S., & Pekovic, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-02638-8 · Cited by 54 · see citing works
Pollock, N. M., Fernandes, J. P., Woodfield, J., Moussa, E., Hlavay, B., Branton, W. G., Wuest, M., Mohammadzadeh, N., Schmitt, L., Plemel, J. R., et al. (2024) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2023.10.022 · Cited by 21 · see citing works
Buonvicino, D., Ranieri, G., & Chiarugi, A. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00331-3 · Cited by 8 · see citing works
A comparative transcriptomic analysis of mouse demyelination models and multiple sclerosis lesions
Aboelnour, E. L., Vanoverbeke, V. R., Maupin, E. A., Hatfield, M. M., & Adams, K. L. (2026) · Nature Communications · doi:10.1038/s41467-026-72383-y · Cited by 4 · see citing works
- Authors
- Skripuletz, T., Hackstette, D., Bauer, K., Gudi, V., Pul, R., Voss, E., Berger, K., Kipp, M., Baumgärtner, W., & Stangel, M.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- RWTH Aachen University (DE)
- University of Veterinary Medicine Hannover, Foundation (DE)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-12-24
- Volume
- 136
- Issue
- 1
- Pages
- 147-167
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2116653422
- Cited by
- 376
- References
- 4
- Citations by year
- 2026: 15 · 2025: 16 · 2024: 30 · 2023: 42 · 2022: 34 · 2021: 25 · 2020: 29 · 2019: 40 · 2018: 21 · 2017: 38 · 2016: 25 · 2015: 26 · 2014: 23 · 2013: 12
- FWCI
- 14.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Funders
- Medizinischen Hochschule Hannover
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- astrocytes, myelin debris clearance, microglia, cuprizone-induced demyelination, remyelination, multiple sclerosis, astrocyte activation, microglial activation, oligodendrocyte precursor cells, oligodendrocyte regeneration, CXCL10, myelin debris, demyelinating disease
- MeSH terms
- Animals, Astrocytes, Axons, Brain, Corpus Callosum, Cuprizone, Demyelinating Diseases, Glial Fibrillary Acidic Protein, Gliosis, Male, Mice, Transgenic, Myelin Sheath, Nerve Fibers, Myelinated, Nerve Regeneration, Nerve Tissue Proteins, Microglia, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review